Basic Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Oct 28, 2018; 24(40): 4554-4564
Published online Oct 28, 2018. doi: 10.3748/wjg.v24.i40.4554
Figure 3
Figure 3 Effect of sofosbuvir and ledipasvir therapy on the frequencies of natural killer cell subsets from chronic hepatitis C patients. A: Frequencies of CD56+ natural killer (NK) cells in peripheral blood mononuclear cells (PBMCs); B: Frequencies of CD56bright NK cells in PBMCs; C: Frequencies of CD56dim NK cells in PBMCs. aP < 0.05 and bP ≤ 0.01 and cP ≤ 0.001, different time points of CHC patients vs healthy controls; dP < 0.05 and eP ≤ 0.01 and fP ≤ 0.001, different time points of CHC patients (2 wk, 4 wk, 8 wk, 12 wk, Pt-12 wk, Pt-24 wk vs 0 wk). NK: Natural killer; CHC: Chronic hepatitis C; Ctrl: Healthy controls; Pt: Post of treatment; PBMCs: Peripheral blood mononuclear cells.